Patient Reported Efficacy of Botulinum Toxin Type A in the Treatment of Chronic Migraine Headaches
Objective: To assess patient reported efficacy of Botulinum toxin type-A for the prophylaxis of migraine headaches in patients with frequent migraine headaches prior to initiation of treatment with Botulinum toxin type-A compared to post treatment. Questions addressed include is there a difference i...
Main Author: | Whitney, Patrick F |
---|---|
Format: | Others |
Published: |
Scholar Commons
2010
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/1806 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=2805&context=etd |
Similar Items
-
Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01) -
MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil
by: Yara Dadalti Fragoso -
Chronic daily headaches
by: Fayyaz Ahmed, et al.
Published: (2012-01-01) -
Outcomes of Chronic Daily Headache in Adolescents
by: J Gordon Millichap
Published: (2007-03-01) -
Chronic Daily Headache in Adolescents
by: J Gordon Millichap
Published: (2006-02-01)